Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for Travere Therapeutics, Inc., €2.9M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Christopher Cline: trading record in brief
Christopher Cline has a single filing on record, published on 15 September 2026: a transaction of €2.9M in Travere Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Cline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 50,508 shares@ US$65.79CommonSEC144:0001950047-26-009521
1 of 1 declaration
